Y Rodríguez, L Novelli, M Rojas, M De Santis… - Journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …
C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley… - Modern …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated clinical syndrome COVID-19 are causing overwhelming morbidity and mortality around the globe …
S Brief, World Health Organization - [accessed May, 2020 - ccs.ca
Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and …
PR Criado, BMZ Abdalla, IC de Assis… - Inflammation …, 2020 - Springer
Background SARS-Cov-2 is a single-stranded RNA virus, a Betacoronavirus, composed of 16 non-structural proteins, with specific roles in replication of coronaviruses. The …
Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and …
Abstract A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …
S Xu, M Chen, J Weng - Pharmacological research, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19), caused by infection with a new type of coronavirus- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerges in December …
A Rauf, A Vijayan, ST John, R Krishnan… - The Indian Journal of …, 2020 - Springer
There is a global concern of increasing number of children presenting with inflammatory syndrome with clinical features simulating Kawasaki disease, during ongoing COVID-19 …